Markets

FDA Approves Abbott’s TactiFlex Duo Ablation Catheter, Sensor Enabled To Treat Patients With Challenging Cases Of Atrial Fibrillation

Sep 8, 2026 · 08:16 AM ET· updated 57m ago

Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ combines pulsed field ablation (PFA) and radiofrequency (RF) energy in a single catheter to treat complex atrial fibrillation (AFib) casesStrong clinical

Why It Matters

Abbott got official approval to sell a new medical tool that helps doctors treat a common heart rhythm problem in tricky cases. When a company gets FDA approval for a new product, it means they can now sell it and make money from it, which is good news to watch.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

ABT107.22

-1.11 (-1.03%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.